Cargando…

Neuropathy in Parkinson’s Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs

BACKGROUND: Severe polyneuropathy has been observed in a number of patients treated for Parkinson’s disease with Levodopa/Carbidopa intestinal gel infusion. This may reflect a rare individual complication or a systematic side effect. OBJECTIVE: To investigate whether peripheral nerve function differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jugel, Constanze, Ehlen, Felicitas, Taskin, Birol, Marzinzik, Frank, Müller, Thomas, Klostermann, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688609/ https://www.ncbi.nlm.nih.gov/pubmed/23818953 http://dx.doi.org/10.1371/journal.pone.0066639

Ejemplares similares

Modulation of Habit Formation by Levodopa in Parkinson's Disease
por: Marzinzik, Frank, et al.
Publicado: (2011)

Differential Influence of Levodopa on Reward-Based Learning in Parkinson's Disease
por: Graef, Susanne, et al.
Publicado: (2010)

Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy
por: Loens, Sebastian, et al.
Publicado: (2017)

Dopamine-Related Reduction of Semantic Spreading Activation in Patients With Parkinson’s Disease
por: Tiedt, Hannes Ole, et al.
Publicado: (2022)

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
por: Othman, Ahmed A, et al.
Publicado: (2014)

Relationships between activity and well‐being in people with parkinson's disease
por: Ehlen, Felicitas, et al.
Publicado: (2018)

Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
por: Othman, Ahmed A., et al.
Publicado: (2015)

Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson’s disease
por: Ehlen, Felicitas, et al.
Publicado: (2020)

Tracing embodied word production in persons with Parkinson’s disease in distinct motor conditions
por: Klostermann, Fabian, et al.
Publicado: (2022)

Deep Brain Stimulation of the Subthalamic Nucleus Improves Lexical Switching in Parkinsons Disease Patients
por: Vonberg, Isabelle, et al.
Publicado: (2016)

Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson's Disease: A Pilot Study
por: De Fabregues, Oriol, et al.
Publicado: (2018)

A Vector Space Model for Neural Network Functions: Inspirations From Similarities Between the Theory of Connectivity and the Logarithmic Time Course of Word Production
por: Fromm, Ortwin, et al.
Publicado: (2020)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Functional roles of the thalamus for language capacities
por: Klostermann, Fabian, et al.
Publicado: (2013)

Age-related dissociation of N400 effect and lexical priming
por: Tiedt, Hannes O., et al.
Publicado: (2020)

The Absoluteness of Semantic Processing: Lessons from the Analysis of Temporal Clusters in Phonemic Verbal Fluency
por: Vonberg, Isabelle, et al.
Publicado: (2014)

Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
por: Morgante, Francesca, et al.
Publicado: (2020)

Population pharmacokinetics of levodopa gel infusion in Parkinson’s disease: effects of entacapone infusion and genetic polymorphism
por: Senek, M., et al.
Publicado: (2020)

Thalamic but Not Subthalamic Neuromodulation Simplifies Word Use in Spontaneous Language
por: Tiedt, Hannes Ole, et al.
Publicado: (2021)

Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-world experience and practical guidance
por: Nyholm, Dag, et al.
Publicado: (2022)

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
por: Bergquist, Filip, et al.
Publicado: (2022)

Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson’s Disease Treatment
por: Nomoto, Yusuke, et al.
Publicado: (2023)

Long‐term safety and effectiveness of levodopa‐carbidopa intestinal gel infusion
por: De Fabregues, Oriol, et al.
Publicado: (2017)

Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients
por: Müller, Thomas, et al.
Publicado: (2022)

Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
por: Nishikawa, Noriko, et al.
Publicado: (2022)

Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease: A Case Report and Literature Review
por: Ueno, Tatsuya, et al.
Publicado: (2021)

Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
por: Garrì, Federica, et al.
Publicado: (2022)

Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease
por: Saqlain, Murshid, et al.
Publicado: (2019)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson'd Disease: Final 12-Month, Open-Label Results
por: Fernandez, Hubert H, et al.
Publicado: (2015)

Abnormal Distracter Processing in Adults with Attention-Deficit-Hyperactivity Disorder
por: Marzinzik, Frank, et al.
Publicado: (2012)

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
por: Othman, Ahmed A., et al.
Publicado: (2017)

Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson's Disease
por: Labeit, Bendix, et al.
Publicado: (2020)

Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Unresponsive Freezing of Gait after Deep Brain Stimulation in Parkinson's Disease
por: González-Herrero, Belén, et al.
Publicado: (2020)

Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
por: Garrì, Federica, et al.
Publicado: (2022)

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report
por: Torres, Viviana, et al.
Publicado: (2022)

Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
por: Kimber, Thomas Edmund, et al.
Publicado: (2019)

Operation of the percutaneous endoscopic gastrostomy-jejunostomy tube without endoscopy in patients with Parkinson’s disease on levodopa-carbidopa intestinal gel infusion therapy
por: Mukai, Yohei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f00bh82hc81llg9q17otoh6ml2